ASX Announcements

24th Dec Update on Second Subscription Placement
11th Dec Change in substantial holding
10th Dec Initial Director's Interest Notice
10th Dec Completion of First Subscription
10th Dec Appendix 3B
10th Dec Prospectus
6th Dec Tranche 1 Placement Funds Received
4th Dec Adoption of Revised Constitution
29th Nov Voluntary Suspension
27th Nov Trading Halt
12th Nov Results of Annual General Meeting
31st Oct Quarterly Review
11th Oct Notice of Annual General Meeting / Proxy Form
7th Oct Notice under s708A(5) of the Corporations Act
7th Oct Reinstatement to Official Quotation
7th Oct $9.3m Strategic Placement
2nd Oct Change of Director's Interest Notice x 4
2nd Oct Appendix 3B
1st Oct Suspension from Official Quotation
26th Sep Trading Halt
16th Sep Appendix 4G and Corporate Governance Statement
16th Sep Annual Report to Shareholders
2nd Sep Appendix 4E Preliminary Final Report
15th Aug Company Update
9th Aug Notice of General Meeting and Proxy Form
9th Aug Capital Raising Update
30th Jul Quarterly Review
19th Jul Appendix 3B
12th Jul EVE Placement Raises $750k
9th Jul THC Global Agreement Update
8th Jul Company Update
20th Jun Meluka Honey Market Update
17th Jun THC Global Agreement Update
21st May Appendix 3B
20th May Response to Appendix 4C Query
15th May THC Global Agreement Update
30th Apr Quarterly Review
9th Apr Singapore and Hong Kong Company Roadshow Presentation
3rd Apr Meluka Honey Secures Distribution for Northern NSW & South East Qld
26th Mar Appendix 3B
26th Mar Placement
18th Mar Meluka Honey US Update
15th Mar Meluka Honey Appoints OpenDNA (Revised)
12th Mar Meluka Honey Appoints OpenDNA to Support Chinese Market Entry
1st Mar Appendix 4D and Half Year Report
25th Feb Appendix 3B
25th Feb EVE to Acquire Remaining 50% of Meluka Health
19th Feb Response to ASX Appendix 4C Query
31st Jan Quarterly Review

Adobe Acrobat Reader 5.0 or later needed to view PDF files. Get Acrobat Reader